Intrasense S.A. (FRA:I8S)

Germany · Delayed Price · Currency is EUR

0.2040

+0.0210 (11.48%)

Last updated: Oct 23, 2026, 9:43 PM CEST

Market Cap	10.85M -24.3%
Revenue (ttm)	2.65M +13.6%
Net Income	-6.48M
EPS	-0.12
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,600
Open	0.1860
Previous Close	0.1830
Day's Range	0.1860 - 0.2040
52-Week Range	0.1590 - 0.3840
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 28, 2026

About Intrasense

Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that automates the identification and measurement of lesions. Intrasense S.A. was incorporated in 2004 and is headquartered in Montpellier, France. Intrase... [Read more]

Industry Health Information Services

Sector Healthcare

Founded 2004

Employees 76

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol I8S

Financial Performance

In 2024, Intrasense's revenue was 2.25 million, a decrease of -32.04% compared to the previous year's 3.31 million. Losses were -5.66 million, 58.0% more than in 2023.

Financial Statements